Page last updated: 2024-11-08

alpha-asarone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

asarone: structure in Merck Index, 9th ed, #847 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

asarone : A phenylpropanoid that is benzene substituted by methoxy groups at positions 1, 2 and 4 and a propen-1-yl group at position 5. It has been isolated from Acorus. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

alpha-asarone : The trans-isomer of asarone. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID636822
CHEMBL ID333306
CHEBI ID78309
SCHEMBL ID528746

Synonyms (99)

Synonym
(e)-2,4,5-trimethoxypropenylbenzene
asarone
MEGXP0_001333
ccris 1596
brn 1910606
asarum camphor
(e)-1,2,4-trimethoxy-5-(1-propenyl)benzene
einecs 220-743-6
trans-isoasaron
asarabacca camphor
benzene, 1,2,4-trimethoxy-5-propenyl-, (e)-
hsdb 3464
trans-isoasarone
benzene, 1,2,4-trimethoxy-5-propenyl-, trans-
benzene, 1,2,4-trimethoxy-5-(1-propenyl)-, (e)-
ai3-36725
trans-asarone
etherophenol
asaron
494-40-6
2,5-trimethoxy-1-propenylbenzene
nsc107257
nsc-107257
benzene,2,4-trimethoxy-5-propenyl-
benzene,2,4-trimethoxy-5-(1-propenyl)-
1,2,4-trimethoxy-5-[(1e)-prop-1-en-1-yl]benzene
inchi=1/c12h16o3/c1-5-6-9-7-11(14-3)12(15-4)8-10(9)13-2/h5-8h,1-4h3/b6-5
1,2,4-trimethoxy-5-propenyl-benzene
1,2,4-trimethoxy-5-trans-propenyl-benzene
(e)-1,2,4-trimethoxy-5-prop-1-enylbenzene
(e)-asarone
benzene, 1,2,4-trimethoxy-5-[(1e)-1-propenyl]-
alpha-asarone, 98%
2883-98-9
alpha-asarone
bdbm50240783
17-(1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-ol; compound with 1,2,4-trimethoxy-5-propenyl-benzene (alphaasarone and cholesterol)
1,2,4-trimethoxy-5-propenylbenzene
CHEMBL333306 ,
chebi:78309 ,
C17846
alpha-asaron
1,2,4-trimethoxy-5-[(e)-prop-1-enyl]benzene
AKOS001590148
4-06-00-07476 (beilstein handbook reference)
unii-dqy9pne5fk
dqy9pne5fk ,
A819627
benzene, 1,2,4-trimethoxy-5-(1e)-1-propen-1-yl-
benzene, 1,2,4-trimethoxy-5-propenyl-
2,4,5-trimethoxy-1-propenylbenzene
benzene, 1,2,4-trimethoxy-5-(1-propenyl)-
nsc 107257
einecs 207-788-7
STL146379
S4772
asarone [who-dd]
benzene, 1,2,4-trimethoxy-5-(1e)-1-propenyl-
asarone [hsdb]
.alpha.-asarone
asarone, alpha-
isoasaron
.alpha.-asaron
1,2,4-trimethoxy-5-(1-propenyl)benzene
BBL028099
SCHEMBL528746
trans-1,2,4-trimethoxy-5-(1-propenyl)benzene
AC-34898
Q-100365
mfcd00064457
HY-N0700
CS-5520
alpha-asarone, analytical standard
a-asarone
isoasaron (6ci)
1,2,4-trimethoxy-5-propenyl-trans-benzene
1,2,4-trimethoxy-5-propenyl-(e)-benzene
1,2,4-trimethoxy-5-(1-propenyl)-(e)-benzene
trans-2,4,5-trimethoxypropenylbenzene
1,2,4-trimethoxy-5-[(1e)-1-propenyl]benzene
trans-(alpha )-asarone
BCP15389
Q419658
??-asarone
(e)-1,2,4-trimethoxy-5-(prop-1-en-1-yl)benzene
(e)-1,2,4-trimethoxy-5-(prop-1-enyl)benzene
alpha-asarone ,(s)
alpha-asarone alpha-asarone
AS-13278
DTXSID00871878
HMS3885L22
CCG-266644
asarone;2,4,5-trimethoxy-1-propenylbenzene
N10790
-asarone;trans-asarone
ze-asarone
1,2,4-trimethoxy-5-(1e)-1-propen-1-ylbenzene
trans-1,2,4-trimethoxy-5-(1-propenyl)benzene trans-1-propenyl-2,4,5-trimethoxybenzene
alpha -asarone

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"In this work we studied the toxic effects of alpha-asarone, a hypolipidemic active principle of Guatteria gaumeri Greenman, on long-term cultures of adult rat hepatocytes cultivated on a feeder layer of 3T3 cells."( alpha-Asarone toxicity in long-term cultures of adult rat hepatocytes.
Chamorro, G; Hernández, A; López, ML; Mendoza-Figueroa, T, 1993
)
1.99
" Both purified eugenol and beta-asarone protected PC-12 cells from the toxic effect of Abeta(1-40)."( Rhizoma acori graminei and its active principles protect PC-12 cells from the toxic effect of amyloid-beta peptide.
Irie, Y; Keung, WM, 2003
)
0.32
"Severe adverse events have been frequently associated with taking the commercially available formulation of α-asarone injection (α-asarone-I)."( Development of intravenous lipid emulsion of α-asarone with significantly improved safety and enhanced efficacy.
Chu, T; Jin, H; Larregieu, CA; Li, H; Ma, WC; Mao, SJ; Zhang, N; Zhang, Q, 2013
)
0.39
" These findings not only remind us that configuration is another important factor for toxicities but also facilitate the understanding of the mechanisms of toxic action of asarone."( Configurational Alteration Results in Change in Hepatotoxicity of Asarone.
Chen, Y; Li, W; Ma, Y; Peng, Y; Wang, X; Zhao, G; Zheng, J, 2023
)
0.91

Pharmacokinetics

ExcerptReferenceRelevance
" The brain was divided into five regions: hippocampus, cortex, brain stem, thalamus and cerebellum, and pharmacokinetic differences were investigated."( Pharmacokinetics of beta-asarone in rabbit blood, hippocampus, cortex, brain stem, thalamus and cerebellum.
Fang, RM; Fang, YQ; Liu, L; Shi, C, 2012
)
0.38
"A selective, accurate and sensitive method using gas chromatography-mass spectroscopy (GC-MS) for the simultaneous determination and pharmacokinetic study of β-asarone, α-asarone, elemicin and cis-methyl isoeugenol in rat plasma was developed and validated."( GC-MS method for determination and pharmacokinetic study of four phenylpropanoids in rat plasma after oral administration of the essential oil of Acorus tatarinowii Schott rhizomes.
Kuang, H; Li, J; Meng, Y; Wang, Q; Wang, Z; Yang, B; Yang, C, 2014
)
0.4
"To study the pharmacokinetic characteristics and absolute bioavailability of α-asarone through dry powder inhalation in rats, and compare with that through oral administration and intravenous injection."( [Pharmacokinetic study on dry powder inhalation administration of α-asarone in rats].
Fu, TM; Guo, LW; Lu, J; Qian, YY; Shi, FY; Zhang, LH, 2015
)
0.42
"A simple, sensitive and selective liquid chromatography-tandem mass spectrometric method was developed and validated for the quantification of α-asarone in mouse plasma with its application to pharmacokinetic studies."( Development of a selective and sensitive LC-MS/MS method for the quantification of α-asarone in mouse plasma and its application to pharmacokinetic studies.
Choi, DK; Ganesan, P; Ko, YT; Ramalingam, P, 2018
)
0.48

Compound-Compound Interactions

ExcerptReferenceRelevance
" The present investigation describes the synergistic anticandidal activity of two asarones (∞ and β) purified from Acorus calamus in combination with three clinically used antifungal drugs (fluconazole, clotrimazole, and amphotericin B)."( Asarones from Acorus calamus in combination with azoles and amphotericin B: a novel synergistic combination to compete against human pathogenic Candida species in vitro.
Aravind, SR; Jacob, J; Kumar, BS; Kumar, SN; Sreelekha, TT, 2015
)
0.42

Bioavailability

ExcerptReferenceRelevance
" Oral bioavailability of ARE in the SMEDDS via the hard capsules and the conventional tablets was evaluated in fasted beagle dogs."( Development of self-microemulsifying drug delivery systems for oral bioavailability enhancement of alpha-Asarone in beagle dogs.
Liu, L; Shi, ZH; Wang, DK; Wang, XY; Zhang, CX; Zhao, P,
)
0.35
" However, the further studies of the skin's stimulation and bioavailability are needed."( [Study on alpha-asarone reservoir-type patch].
Chen, HL; Gao, JQ; Hu, Y; Liang, WQ; Wu, Z, 2007
)
0.74
" Pharmacokinetic study of oral administration to male rats at 10 mg/Kg suggested that the relative bioavailability of alpha-Asarone was significantly improved in alpha-Asarone-SLN group compared to alpha-Asarone solution group."( Preparation and characterization of solid lipid nanoparticles loaded with alpha-Asarone.
Li, X; Wang, D; Wang, X; Ye, L,
)
0.57
" The final patch showed a high efficiency, with a relative bioavailability of 1,494%."( Development and evaluation of α-asarone transdermal patches based on hot-melt pressure-sensitive adhesives.
Liang, W; Liang, Y; Yu, Z, 2013
)
0.39
"The aim of this study was to load amorphous hydrophobic drug into ordered mesoporous silica (SBA-15) by supercritical carbon dioxide technology in order to improve the dissolution and bioavailability of the drug."( Loading amorphous Asarone in mesoporous silica SBA-15 through supercritical carbon dioxide technology to enhance dissolution and bioavailability.
Bai, X; Li, F; Li, G; Pan, X; Quan, G; Wu, C; Wu, Q; Zhang, Z; Zhou, C, 2015
)
0.42
"To study the pharmacokinetic characteristics and absolute bioavailability of α-asarone through dry powder inhalation in rats, and compare with that through oral administration and intravenous injection."( [Pharmacokinetic study on dry powder inhalation administration of α-asarone in rats].
Fu, TM; Guo, LW; Lu, J; Qian, YY; Shi, FY; Zhang, LH, 2015
)
0.42
" In our study, we sought to explore the biopharmaceutical classification of ARE, elucidate the mechanisms behind ARE absorption, and to develop a viable formulation to improve the oral bioavailability of ARE."( Dissolution and bioavailability enhancement of alpha-asarone by solid dispersions via oral administration.
Deng, L; Gong, T; Sun, X; Wang, Y; Zhang, ZR, 2017
)
0.71
"Based on the data obtained from the literature search, the pharmacokinetic studies of α- and β-asarone revealed that their oral bioavailability in rodents is poor with a short plasma half-life."( Pharmacology and toxicology of α- and β-Asarone: A review of preclinical evidence.
Chellian, R; Mohamed, Z; Pandy, V, 2017
)
0.46
"The ADME data of current investigation has shown good oral bioavailability of β-asarone."( Evaluation of In Silico Anti-parkinson Potential of β-asarone.
Gupta, M; Kant, K; Kumar, A; Sharma, R, 2018
)
0.48

Dosage Studied

ExcerptRelevanceReference
" After daily dosing per os of 80 mg/kg of alpha-asarone and the amino and metoxi analogs for seven days to hypercholesterolemic male rats, cholesterol decreased 57."( [Pharmacology and toxicology of Guatteria gaumeri and alpha-asarone].
Chamorro, G; Mendoza, T; Salazar, M; Salazar, S,
)
0.64
" The summary mainly includes the dosage forms, pharmacokinetics, bioavailability, pharmacological effects, toxicology and clinical uses during the past ten years."( [A review of recent ten-year study on alpha-asarone].
Wu, FL; Wu, JM; Zhao, LH, 2007
)
0.61
" Dose-response and time-course anti-proliferation effects were examined by MTT assay."( Beta-asarone induces LoVo colon cancer cell apoptosis by up-regulation of caspases through a mitochondrial pathway in vitro and in vivo.
Ling, BF; Liu, SL; Wang, RP; Wu, J; Zhou, JY; Zou, X, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
anticonvulsantA drug used to prevent seizures or reduce their severity.
GABA modulatorA substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
asaroneA phenylpropanoid that is benzene substituted by methoxy groups at positions 1, 2 and 4 and a propen-1-yl group at position 5. It has been isolated from Acorus.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)IC50 (µMol)2.94820.00000.79498.9000AID1168896; AID1168897
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (10)

Processvia Protein(s)Taxonomy
cholesterol biosynthetic process3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
visual learning3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
coenzyme A metabolic process3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
negative regulation of protein catabolic process3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
negative regulation of protein secretion3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
long-term synaptic potentiation3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
regulation of ERK1 and ERK2 cascade3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
negative regulation of amyloid-beta clearance3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
isoprenoid biosynthetic process3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
sterol biosynthetic process3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (5)

Processvia Protein(s)Taxonomy
hydroxymethylglutaryl-CoA reductase (NADPH) activity3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
protein binding3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
GTPase regulator activity3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
NADPH binding3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
coenzyme A binding3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (3)

Processvia Protein(s)Taxonomy
peroxisomal membrane3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
endoplasmic reticulum3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
endoplasmic reticulum membrane3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
endoplasmic reticulum membrane3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
peroxisomal membrane3-hydroxy-3-methylglutaryl-coenzyme A reductaseHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (42)

Assay IDTitleYearJournalArticle
AID1101911Mosquitocidal activity against fourth-instar larvae of Aedes aegypti assessed as mortality at 100 ug/ml after 24 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID1502967Hypercholesterolemic activity in rat assessed as reduction in triglyceride level at 4 to 25 mg/kg/day2017European journal of medicinal chemistry, Nov-10, Volume: 140Lipid lowering agents of natural origin: An account of some promising chemotypes.
AID1502969Hypercholesterolemic activity in male rat assessed as reduction in triglyceride level at 80 mg/kg/day for 7 days2017European journal of medicinal chemistry, Nov-10, Volume: 140Lipid lowering agents of natural origin: An account of some promising chemotypes.
AID1101905Antimicrobial activity against Aspergillus parasiticus at 100 ug/ml after 72 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID487629Inhibition of Schizosaccharomyces pombe HMG-CoA reductase by spectrophotometry2010Bioorganic & medicinal chemistry, Jun-15, Volume: 18, Issue:12
Design, synthesis, and docking of highly hypolipidemic agents: Schizosaccharomyces pombe as a new model for evaluating alpha-asarone-based HMG-CoA reductase inhibitors.
AID93426In vitro inhibition of human platelet aggregation induced by 10 uM ADP after incubation at 100 uM2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
AID1101907Antimicrobial activity against Candida albicans at 100 ug/ml after 72 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID1101903Antimicrobial activity against Escherichia coli at 100 ug/ml after 72 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID488646Induction of cAMP level in mouse NIE115 cells at 50 uM after 30 mins by Alphascreen cAMP assay2010Journal of natural products, Jun-25, Volume: 73, Issue:6
Compounds from Acorus tatarinowii: determination of absolute configuration by quantum computations and cAMP regulation activity.
AID224690Effect on acute pulmonary thromboembolism in mice at 50 mg/kg expressed as no. of killed or paralyzed to no. of tested observed after 10 min2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
AID332912Antimicrobial activity Propionibacterium acnes ATCC 11827 after 2 days by broth dilution method1994Journal of natural products, Jan, Volume: 57, Issue:1
Naturally occurring antiacne agents.
AID1101910Antifeedant activity against Helicoverpa zea (corn earworm) at 100 ug/ml after 6 days2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID1101912Mosquitocidal activity against fourth-instar larvae of Aedes aegypti assessed as mortality at 200 ug/ml after 24 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID1101913Mosquitocidal activity against fourth-instar larvae of Aedes aegypti assessed as mortality after 24 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID1101904Antimicrobial activity against Fusarium oxysporum at 100 ug/ml after 72 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID224688Effect on acute pulmonary thromboembolism in mice at 100 mg/kg expressed as no. of killed or paralyzed to no. of tested observed after 10 min2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
AID1502968Hypercholesterolemic activity in male rat assessed as reduction in cholesterol level at 80 mg/kg/day for 7 days2017European journal of medicinal chemistry, Nov-10, Volume: 140Lipid lowering agents of natural origin: An account of some promising chemotypes.
AID1101908Antifeedant activity against Manduca sexta at 100 ug/ml after 6 days2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID1168897Inhibition of human HMG-CoA reductase after 30 mins2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors.
AID1101902Antimicrobial activity against Staphylococcus aureus at 100 ug/ml after 72 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID1101906Antimicrobial activity against Aspergillus flavus at 100 ug/ml after 72 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID1502970Hypercholesterolemic activity in rat assessed as reduction in cholesterol level at 80 mg/kg/day for 8 days2017European journal of medicinal chemistry, Nov-10, Volume: 140Lipid lowering agents of natural origin: An account of some promising chemotypes.
AID337835Antifungal activity against Saccharomyces cerevisiae ATCC 7754 after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID1502966Hypercholesterolemic activity in rat assessed as reduction in plasma cholesterol level at 4 to 25 mg/kg/day2017European journal of medicinal chemistry, Nov-10, Volume: 140Lipid lowering agents of natural origin: An account of some promising chemotypes.
AID1101917Antimicrobial activity against Candida parapsilosis at 100 ug/ml after 72 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID337836Antifungal activity against Candida albicans ATCC 18804 after 2 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID93427In vitro inhibition of human platelet aggregation induced by 10 uM ADP after incubation at 150 uM2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
AID1101914Nematicidal activity against Panagrellus redivivus assessed as mortality at 100 ug/ml after 24 hr by microscopic analysis2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID337837Antifungal activity against Pityrosporum ovale ATCC 14521 after 3 days by broth dilution method1993Journal of natural products, Feb, Volume: 56, Issue:2
Combination effects of antifungal nagilactones against Candida albicans and two other fungi with phenylpropanoids.
AID224858Effect on acute pulmonary thromboembolism in mice at 50 mg/kg2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
AID378129Inhibition of human liver microsome CYP2D6 in assessed as [14C]formaldehyde formation2005Journal of natural products, Jan, Volume: 68, Issue:1
Potent CYP3A4 inhibitory constituents of Piper cubeba.
AID1168896Inhibition of human HMG-CoA reductase activity using NADPH by spectrophotometrically2014Bioorganic & medicinal chemistry, Nov-01, Volume: 22, Issue:21
Synthesis and highly potent hypolipidemic activity of alpha-asarone- and fibrate-based 2-acyl and 2-alkyl phenols as HMG-CoA reductase inhibitors.
AID93429In vitro inhibition of human platelet aggregation induced by 10 uM ADP after incubation at 250 uM2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
AID1080381Nematicidal activity against Bursaphelenchus xylophilus assessed as nematode mortality at 2 mg/mL measured 24 hr post dose by microscopy2008Journal of agricultural and food chemistry, Aug-27, Volume: 56, Issue:16
Nematicidal activity of plant essential oils and components from coriander (Coriandrum sativum), Oriental sweetgum (Liquidambar orientalis), and valerian (Valeriana wallichii) essential oils against pine wood nematode (Bursaphelenchus xylophilus).
AID1101909Antifeedant activity against Heliothis virescens (tobacco budworm) at 100 ug/ml after 6 days2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID378128Inhibition of human liver microsome CYP3A4 in assessed as [14C]formaldehyde formation2005Journal of natural products, Jan, Volume: 68, Issue:1
Potent CYP3A4 inhibitory constituents of Piper cubeba.
AID93428In vitro inhibition of human platelet aggregation induced by 10 uM ADP after incubation at 200 uM2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
AID1101915Nematicidal activity against Caenorhabditis elegans assessed as mortality at 100 ug/ml after 24 hr by microscopic analysis2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID224856Effect on acute pulmonary thromboembolism in mice at 100 mg/kg2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
AID1101916Antimicrobial activity against Pichia kudriavzevii at 100 ug/ml after 72 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID1101901Antimicrobial activity against Staphylococcus epidermidis at 100 ug/ml after 72 hr2002Journal of agricultural and food chemistry, Jul-31, Volume: 50, Issue:16
Pest-managing efficacy of trans-asarone isolated from Daucus carota L. seeds.
AID93430In vitro inhibition of human platelet aggregation induced by 10 uM ADP after incubation at 300 uM2000Journal of medicinal chemistry, Oct-05, Volume: 43, Issue:20
Synthesis and hypolipidemic and antiplatelet activities of alpha-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (278)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (6.47)18.7374
1990's17 (6.12)18.2507
2000's48 (17.27)29.6817
2010's149 (53.60)24.3611
2020's46 (16.55)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.12 (24.57)
Research Supply Index5.66 (2.92)
Research Growth Index5.11 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.35%)5.53%
Reviews10 (3.50%)6.00%
Case Studies1 (0.35%)4.05%
Observational0 (0.00%)0.25%
Other274 (95.80%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]